Voyager Therapeutics Inc

-0.21 (-3.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)225.86M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.02 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$5.90
50-Day MA$5.66
200-Day MA$6.31
See more pivots

Voyager Therapeutics Inc Stock, NASDAQ:VYGR

64 Sidney Street, Cambridge, Massachusetts 02139
United States of America
Phone: +1.857.259.5340
Number of Employees: 101


Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.